Esther H Chang

This inventor holds 16 USPTO granted patents and 4 published patent applications, plus 9 CIPO patents and 7 EPO patents. Top assignees: Georgetown University, Synergene Therapeutics, Inc., Aventis Pharma Deutschland, Gmbh. Active years: 2000-2025.

USPTO Granted Patents = 16 (Patent Applications = 4)

% Patents Active = 62.5

CIPO Patents = 9 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 86(Granted Patents)

Location History:

Chevy Chase, MD (US) (2000 - 2014)
Potomac, MD (US) (2013 - 2024)

Company Filing History:

14 out of 498

Georgetown University

patents

3 out of 3

Synergene Therapeutics, Inc.

patents

1 out of 330

Aventis Pharma Deutschland, Gmbh

patents

4. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12274784 - Methods for reducing side effects of immunotherapy (2025-04-14),

2. 11951167 - Targeted liposomes (2024-04-09),

3. 10668172 - Treatment for exposure to nerve agent (2020-06-02),

4. 9878055 - Treatment for exposure to nerve agent (2018-01-30),

5. 9480750 - Preparation of antibody or an antibody fragment targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof (2016-11-01),

6. 9034330 - Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof (2015-05-19),

7. 9034329 - Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof (2015-05-19),

8. 8865127 - Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent (2014-10-21),

9. 8859274 - Antibody fragment-targeted immunoliposomes for systemic gene delivery (2014-10-14),

10. 8617514 - Tumor-targeted nanodelivery systems to improve early MRI detection of cancer (2013-12-31),

11. 7780882 - Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent (2010-08-24),

12. 7479276 - Antibody fragment-targeted immunoliposomes for systemic gene delivery (2009-01-20),

13. 6803360 - Compositions and methods for reducing radiation and drug resistance in cells (2004-10-12),

14. 6749863 - Targeted liposome gene delivery (2004-06-15),

15. 6723706 - Modified antisense nucleotides complementary to a section of the human Ha-ras gene (2004-04-20),

Title: The Innovative Journey of Esther H Chang

Introduction: Esther H Chang, a pioneering inventor based in Potomac, MD (US), has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Esther H Chang holds several patents in the areas of artificial intelligence, renewable energy, and healthcare technology, showcasing her diverse range of expertise and innovative spirit.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Esther H Chang has led successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout her career, Esther H Chang has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life, demonstrating her ability to work effectively in multidisciplinary teams.

Conclusion: Esther H Chang's relentless pursuit of innovation and her commitment to pushing the boundaries of technology make her a true trailblazer in the world of inventions. Her impact continues to inspire future generations of inventors to think boldly and create solutions that shape the world we live in.